MediWound Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
MediWound Ltd. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue20.2218.6926.5023.7621.7631.793.40
Cost of Revenue17.5915.1113.3314.9914.22-0.642.09
Gross Profit2.633.5813.178.777.5531.791.31
Operating Expenses
Research & Development8.887.4710.1810.267.704.974.07
Selling, General & Administrative12.9111.6110.659.458.699.317.94
Operating Expenses22.0219.2920.8319.9916.3914.2812.81
Operating Income-19.38-15.71-7.66-11.22-8.8417.51-11.50
Other Income/Expense
Interest Income2.052.340.270.010.300.000.41
Interest Expense0.75-0.27-0.100.90-0.830.000.89
Other Income/Expense-10.757.87-11.40-0.51-0.45-0.637.32
Income
Income Before Tax-30.16-6.95-19.52-13.52-9.2816.91-5.67
Income Tax Expense0.060.190.080.030.002.980.00
Net Income-30.22-7.14-19.60-13.55-9.2016.81-1.06
Net Income - Continuous Operations-30.22-6.72-19.60-13.550.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-27.93-3.76-6.39-11.38-7.7517.13-4.20
EBIT-29.41-5.06-7.66-12.62-8.8415.98-4.77
Depreciation & Amortization0.230.631.270.281.09-0.510.04
Earnings Per Share
Basic EPS-3.00-1.00-4.00-3.00-2.001.00-
Diluted EPS-3.00-1.00-4.00-3.00-2.001.00-
Basic Shares Outstanding9.969.014.993.893.882.9327.11
Diluted Shares Outstanding9.969.014.993.893.882.3427.11